ALK	Anaplastic Lymphoma Kinase
AUC	Area Under the Curve
CI	Confidence Intervals
CT	Computed Tomography
DC	Disease Control
DL	Deep Learning
ECOG	Eastern Cooperative Oncology Group
EGFR	Epidermal Growth Factor Receptor
FU	Follow Up
ICI	Immune Checkpoint Inhibitor
IHC	Immunohistochemistry
IO	Immunotherapy
LC	Lung Cancer
LR	Logistic Regression
ML	Machine Learning
MRI	Magnetic Resonance Imaging
mRMR	minimum Redundancy Maximum Relevance
NSCLC	Non-Small-Cell Lung Cancer
OD	Optical Density
OS	Overall Survival
PD	Progressive Disease
PD-L1	Programmed Death Ligand-1
PET	Positron Emission Tomography
PFS	Progression Free Survival
PR	Partial Response
RECIST	Response Evaluation Criteria in Solid Tumors
ROC	Receiver Operating Characteristic
SD	Stable Disease
SFS	Sequential Forward Selection
SN	Sensitivity
SOC	Standard of Care
SP	Specificity
Tr-set	Discovery Training Set
US	Ultrasound
X-set	External Test Set
YJ	Youden-J